iHub News
2月前
Neogen tops estimates as food safety segment drives growthApril 9, 2026 10:56 AM
IH Market News
Neogen Corp. (NASDAQ:NEOG) reported third-quarter results on Thursday that came in ahead of analyst forecasts, supported by strong performance in its food safety business.Shares of the company rose 1.16% in premarket trading following the announcement.The food safety and animal health company posted adjusted earnings per share of $0.09, surpassing the consensus estimate of $0.06 by $0.03.Quarterly revenue totaled $211.2 million, exceeding analysts’ expectations of $204.49 million, although it declined 4.4% compared with $221.0 million in the same quarter last year.Growth was led by the Food Safety segment, which recorded 4.0% core revenue growth and continued the momentum seen in the previous quarter. Regional expansion was strongest in Latin America and Europe. In contrast, the Animal Safety segment saw core revenue decline 8.7%, largely due to supply challenges involving third-party vendors.Neogen also raised its fiscal 2026 full-year revenue outlook, now expecting revenue between $857 million and $860 million. The midpoint of $858.5 million is above the consensus estimate of $850.9 million. Previously, the company had guided for revenue in the range of $845 million to $855 million.Adjusted EBITDA for the quarter reached $48.2 million, with a margin of 22.8%, representing a 110 basis point improvement compared with the second quarter despite lower revenue.The improved margins were driven by disciplined cost management, with adjusted operating expenses declining 9% sequentially. The reduction reflects the full impact of a workforce reduction implemented during the first quarter.Adjusted net income for the quarter totaled $19.4 million. Neogen reiterated its full-year adjusted EBITDA guidance of approximately $175 million and said it expects to generate positive free cash flow in fiscal 2026.The company also confirmed that its Petrifilm manufacturing transition remains on schedule for November 2027, with early product validation tests delivering encouraging results.Neogen Corporation stock price
Original: Neogen tops estimates as food safety segment drives growth
US Market News
2月前
Neogen to Release Third-Quarter Fiscal Year 2026 Financial Results on April 9, 2026March 30, 2026 2:50 PM
Business Wire
Neogen® Corporation (NASDAQ: NEOG) will issue its third-quarter earnings release before the opening of the market on Thursday, April 9, 2026. Executives from the company will host a webcast and conference call later that morning, beginning at 8:00 a.m. Eastern time. During the call, Neogen management will provide a financial overview and business update of the company’s performance for the third-quarter of fiscal year 2026.
The conference call can be accessed by dialing:
Toll-Free - North America: 1-800-549-8228
International: (+1) 646-564-2877
Conference ID: 70064#
The live webcast can be accessed through Neogen’s Investor Relations webpage, neogen.com/investor-relations, under the “Events & Presentations” subheading.
A replay of the conference call and webcast will be available shortly following the conclusion of the call and can be accessed by dialing:
Toll-Free - North America: (1) 888-660-6264
International: (+1) 646-517-3975
Passcode: 70064 #
It will also be available on Neogen’s Investor Relations website at neogen.com/investor-relations.
About Neogen
Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. A world leader in these fields, Neogen has a presence in over 140 countries with a dedicated network of scientists and technical experts focused on delivering optimized products and technology for its customers.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260326431610/en/
Investor Contact
Scott Gleason
(435) 395-0254
sgleason@neogen.com
Media Contact:
Lauren White
lwhite@neogen.com
Original: Neogen to Release Third-Quarter Fiscal Year 2026 Financial Results on April 9, 2026
iHub News
3月前
Zoetis shares slip after announcing $160M acquisition of Neogen genomics unitMarch 2, 2026 11:14 AM
IH Market News
Shares of Zoetis Inc (NYSE:ZTS) edged 1.1% lower to $129.72 in premarket trading on Monday after the animal health company revealed plans to acquire the animal genomics division of Neogen Corporation (NASDAQ:NEOG) in a deal valued at $160 million.The transaction will give Zoetis access to Neogen’s genetic testing capabilities and data analytics platforms, which the company intends to use to enhance disease prediction and enable more tailored healthcare solutions for animals.Neogen’s genomics business operates five laboratories located in the United States, Brazil, Australia, China and the United Kingdom, along with an additional office in Canada, serving customers across more than 120 countries worldwide.Zoetis said the acquisition is expected to close during the second half of calendar year 2026, subject to customary conditions.The company’s shares had gained approximately 4.2% during 2025 prior to Monday’s decline.Zoetis stock price
Original: Zoetis shares slip after announcing $160M acquisition of Neogen genomics unit
US Market News
4月前
Neogen Issues Voluntary Nationwide Recall of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile SolutionJanuary 28, 2026 6:27 PM
Business Wire
Neogen Corporation (NASDAQ: NEOG) is voluntarily recalling all lots within expiry of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution, for use in dogs, cats, and horses, to the veterinarian level. Neogen distributes this product, which is manufactured by a third-party supplier. This recall has been initiated due to microbial contamination in certain lots of 10 mL/50 mg product vials. Neogen received a number of reports of adverse events in horses following intraarticular injections of this product, which is inconsistent with its labeled, intended use. To date, Neogen has not received reports of adverse events when used in a manner consistent with the labeled use.
While the company’s investigation into this issue is ongoing, out of an abundance of caution the 2mL/20mg product vials are also being recalled. The company is proactively working with the FDA on this matter.
Risk Statement: This product is labeled as a sterile solution, but due to microbial contamination of certain lots, the recalled lots should no longer be considered sterile. Vials that contain a microbial contaminant potentially result in infection in the animal. The risk is particularly acute when used as an intraarticular injection (which is inconsistent with its labeled, intended use). There also is risk if used according to the label as a topical wound management system in surgical wounds, burns, ulcers, and autograft procedures. To date, Neogen has not received reports of adverse events when used in a manner consistent with the labeled use.
The product is intended for use as a topical wound management system and is packaged in vials of 2mL/20 mg (UPC Code 726087089386) and 10mL/50mg (UPC Code 726087089393).
The subject product lots within expiry include the following:
2 mL/20 mg lot numbers: 0236735, 0236736, 0336746, 0336747, 0536760, 0536761, 0636768, 0636769, 0836792, 0836785, 0836788, 0836789, 0936794, 0936795, 1036801, 1036802, 1036803, 1036804, 1136807, 1136808, 0246837, 0246838, 4L001B, 4L002
10 mL/50 mg lot numbers: 0136731, 0736777, 0346843, 5A001
Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution was distributed nationwide to animal health distributors and veterinarians.
Neogen is notifying its distributors and direct customers by email and is arranging for return of all recalled products. Anyone that has HYCOAT which is being recalled should discontinue use and quarantine product.
Customers with questions regarding this recall can contact Neogen Animal Safety Customer Support Monday through Friday, 8AM-5PM ET at 859-254-1221 or via email at AnimalHealth@neogen.com for return shipping instructions. Customers can work through their distributor for product returns.
Veterinarians that have experienced any problems that may be related to using this product should report to the FDA's Center for Veterinary Medicine on FORM FDA 1932a, “Veterinary Adverse Experience, Lack of Effectiveness or Product Defect Report.”
Download and submit Form FDA 1932a available at https://www.fda.gov/reportanimalae, or
Contact FDA at 1-888-FDA-VETS to request this form.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
No other Neogen products are affected by this field action.
About Neogen
Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. A world leader in these fields, Neogen has a presence in over 140 countries with a dedicated network of scientists and technical experts focused on delivering optimized products and technology for its customers.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260128021369/en/
PR@Neogen.com
Original: Neogen Issues Voluntary Nationwide Recall of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution
georgie18
1年前
NEOG...$6.50...🥳
georgie18
Member Level
Re: georgie18 post# 681622
Monday, May 12, 2025 9:34:06 AM
Post#
682020
of 682105
NEOG...$6.34...🥳...Getting some traction here...Open Gap to fill in the $7 range...
georgie18
Member Level
Re: georgie18 post# 392993
Wednesday, May 07, 2025 3:53:56 PM
Post#
393154
of 393211
NEOG...$5.93...🥳...Own $5.08 range to $5.20 Range...Took some profit on Friday...
georgie18
Member Level
Re: georgie18 post# 681173
Sunday, May 04, 2025 10:21:06 AM
Post#
681230
of 681622
NEOG...$5.75...🥳...Own $5.08 range to $5.20 Range...Took some profit on Friday...
georgie18
Member Level
Re: georgie18 post# 392776
Friday, May 02, 2025 1:31:58 PM
Post#
392962
of 392992
NEOG...$5.51...Picher Squeeze Breakout here...🥳
georgie18
Member Level
Re: georgie18 post# 680431
Monday, April 28, 2025 3:29:57 PM
Post#
680633
of 681173
NEOG...Added $5.08s to $5.12s...🥳
georgie18
Member Level
Re: georgie18 post# 392678
Friday, April 25, 2025 9:40:38 AM
Post#
392685
of 392775
NEOG...$5.14...🥳...300,000 Volume in already...🥳
georgie18
Member Level
Re: None
Friday, April 25, 2025 8:15:28 AM
Post#
680404
of 680430
NEOG...$5.20...🥳...https://schrts.co/qkuyFWyn ...Pincher Squeeze in play here...Open Gap in the $7 Range...
georgie18
1年前
NEOG...$6.34...🥳...Getting some traction here...Open Gap to fill in the $7 range...
georgie18
Member Level
Re: georgie18 post# 392993
Wednesday, May 07, 2025 3:53:56 PM
Post#
393154
of 393211
NEOG...$5.93...🥳...Own $5.08 range to $5.20 Range...Took some profit on Friday...
georgie18
Member Level
Re: georgie18 post# 681173
Sunday, May 04, 2025 10:21:06 AM
Post#
681230
of 681622
NEOG...$5.75...🥳...Own $5.08 range to $5.20 Range...Took some profit on Friday...
georgie18
Member Level
Re: georgie18 post# 392776
Friday, May 02, 2025 1:31:58 PM
Post#
392962
of 392992
NEOG...$5.51...Picher Squeeze Breakout here...🥳
georgie18
Member Level
Re: georgie18 post# 680431
Monday, April 28, 2025 3:29:57 PM
Post#
680633
of 681173
NEOG...Added $5.08s to $5.12s...🥳
georgie18
Member Level
Re: georgie18 post# 392678
Friday, April 25, 2025 9:40:38 AM
Post#
392685
of 392775
NEOG...$5.14...🥳...300,000 Volume in already...🥳
georgie18
Member Level
Re: None
Friday, April 25, 2025 8:15:28 AM
Post#
680404
of 680430
NEOG...$5.20...🥳...https://schrts.co/qkuyFWyn ...Pincher Squeeze in play here...Open Gap in the $7 Range...
georgie18
1年前
NEOG...$5.93...🥳...Own $5.08 range to $5.20 Range...Took some profit on Friday...
georgie18
Member Level
Re: georgie18 post# 681173
Sunday, May 04, 2025 10:21:06 AM
Post#
681230
of 681622
NEOG...$5.75...🥳...Own $5.08 range to $5.20 Range...Took some profit on Friday...
georgie18
Member Level
Re: georgie18 post# 392776
Friday, May 02, 2025 1:31:58 PM
Post#
392962
of 392992
NEOG...$5.51...Picher Squeeze Breakout here...🥳
georgie18
Member Level
Re: georgie18 post# 680431
Monday, April 28, 2025 3:29:57 PM
Post#
680633
of 681173
NEOG...Added $5.08s to $5.12s...🥳
georgie18
Member Level
Re: georgie18 post# 392678
Friday, April 25, 2025 9:40:38 AM
Post#
392685
of 392775
NEOG...$5.14...🥳...300,000 Volume in already...🥳
georgie18
Member Level
Re: None
Friday, April 25, 2025 8:15:28 AM
Post#
680404
of 680430
NEOG...$5.20...🥳...https://schrts.co/qkuyFWyn ...Pincher Squeeze in play here...Open Gap in the $7 Range...
georgie18
1年前
NEOG...$5.75...🥳...Own $5.08 range to $5.20 Range...Took some profit on Friday...
georgie18
Member Level
Re: georgie18 post# 392776
Friday, May 02, 2025 1:31:58 PM
Post#
392962
of 392992
NEOG...$5.51...Picher Squeeze Breakout here...🥳
georgie18
Member Level
Re: georgie18 post# 680431
Monday, April 28, 2025 3:29:57 PM
Post#
680633
of 681173
NEOG...Added $5.08s to $5.12s...🥳
georgie18
Member Level
Re: georgie18 post# 392678
Friday, April 25, 2025 9:40:38 AM
Post#
392685
of 392775
NEOG...$5.14...🥳...300,000 Volume in already...🥳
georgie18
Member Level
Re: None
Friday, April 25, 2025 8:15:28 AM
Post#
680404
of 680430
NEOG...$5.20...🥳...https://schrts.co/qkuyFWyn ...Pincher Squeeze in play here...Open Gap in the $7 Range...
georgie18
1年前
NEOG...$5.51...Picher Squeeze Breakout here...🥳
georgie18
Member Level
Re: georgie18 post# 680431
Monday, April 28, 2025 3:29:57 PM
Post#
680633
of 681173
NEOG...Added $5.08s to $5.12s...🥳
georgie18
Member Level
Re: georgie18 post# 392678
Friday, April 25, 2025 9:40:38 AM
Post#
392685
of 392775
NEOG...$5.14...🥳...300,000 Volume in already...🥳
georgie18
Member Level
Re: None
Friday, April 25, 2025 8:15:28 AM
Post#
680404
of 680430
NEOG...$5.20...🥳...https://schrts.co/qkuyFWyn ...Pincher Squeeze in play here...Open Gap in the $7 Range...
DewDiligence
4年前
NEOG FY3Q22 financials:
https://www.prnewswire.com/news-releases/neogen-announces-third-quarter-results-301509892.html Net income for the third quarter was $5,443,000, or $0.05 per share, adversely impacted by $10.6 million of professional fees incurred in connection with Neogen's plan to combine 3M's Food Safety business with the company's existing operations, which was announced on December 14, 2021. Excluding the 3M deal-related costs, net income for the quarter would have been $13,600,000, or $0.13 per share, compared to $13,377,000, or $0.12 per share, in the previous year's third quarter. No CC.
stocktrademan
12年前
$NEOG DD Notes ~ http://www.ddnotesmaker.com/NEOG
bullish very long term
$NEOG recent news/filings
## source: finance.yahoo.com
Wed, 08 Oct 2014 21:07:30 GMT ~ NEOGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
read full: http://biz.yahoo.com/e/141008/neog8-k.html
*********************************************************
Sat, 04 Oct 2014 00:08:14 GMT ~ 10-Q for Neogen Corp.
read full: http://www.companyspotlight.com/routers/headline/18881/10004/6399840?cp_code=YAH1&1412381294
*********************************************************
Fri, 03 Oct 2014 17:31:35 GMT ~ NEOGEN CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
read full: http://biz.yahoo.com/e/141003/neog8-k.html
*********************************************************
Wed, 01 Oct 2014 20:45:06 GMT ~ NEOGEN CORP Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
read full: http://biz.yahoo.com/e/141001/neog8-k.html
*********************************************************
Wed, 01 Oct 2014 17:00:00 GMT ~ Neogen acquires BioLumix
[PR Newswire] - LANSING, Mich., Oct. 1, 2014 /PRNewswire/ -- Neogen Corporation (NEOG) announced today that, effective Sept. 30, it has acquired all the outstanding stock of BioLumix, Inc., an Ann Arbor, Mich.-based manufacturer and marketer of automated systems for the detection of microbial contaminants. The BioLumix business will be consolidated with Neogen's closely related Soleris® technology, which is widely used for the detection of spoilage organisms in several food industries, as well as the nutraceutical market. "Combining of the Soleris and BioLumix technologies, market bases, and outstanding technical staffs will greatly enhance both businesses and offer significant labor saving rapid solutions for the food, pharmaceutical, and personal care businesses," said James Herbert, Neogen's chief executive officer and chairman.
read full: http://finance.yahoo.com/news/neogen-acquires-biolumix-170000134.html
*********************************************************
$NEOG charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$NEOG company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/NEOG/company-info
Ticker: $NEOG
OTC Market Place: Not Available
CIK code: 0000711377
Company name: Neogen Corp.
Company website: http://www.neogen.com
Incorporated In: MI, USA
$NEOG share structure
## source: otcmarkets.com
Market Value: $1,625,873,839 a/o Oct 28, 2014
Shares Outstanding: 36,926,501 a/o Aug 31, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 1.06
$NEOG extra dd links
Company name: Neogen Corp.
Company website: http://www.neogen.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=NEOG+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=NEOG+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=NEOG+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/NEOG/news - http://finance.yahoo.com/q/h?s=NEOG+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/NEOG/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/NEOG/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=NEOG+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/NEOG
DTCC (dtcc.com): http://search2.dtcc.com/?q=Neogen+Corp.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Neogen+Corp.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Neogen+Corp.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.neogen.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.neogen.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.neogen.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/NEOG
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000711377&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/NEOG/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/NEOG/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=NEOG&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=NEOG
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/NEOG/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=NEOG+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=NEOG+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=NEOG
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=NEOG
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=NEOG+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/NEOG/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=NEOG+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/NEOG.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=NEOG
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/NEOG/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/NEOG
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/NEOG
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/NEOG:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=NEOG
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=NEOG
$NEOG DD Notes ~ http://www.ddnotesmaker.com/NEOG
Penny Roger$
14年前
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets a diverse line of products dedicated to food and animal safety. The Company’s food safety segment consists primarily of diagnostic test kits and complementary products (dehydrated culture media) marketed by company sales personnel in North America, the United Kingdom and other parts of Europe, Mexico and Brazil, and by distributors elsewhere to food producers and processors to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, genetic modifications, ruminant by-products, drug residues, pesticide residues and general sanitation concerns. Neogen’s animal safety segment is engaged in the development, manufacture and marketing of pharmaceuticals, rodenticides, disinfectants, vaccines, veterinary instruments, topicals and diagnostic products and genetic testing services for the worldwide animal safety market.
http://www.google.com/finance?q=NEOG